Company
United StatesEvive Biopharmaceutical (Beijing), Ltd. – FDA Inspections
Inspection records and compliance data for Evive Biopharmaceutical (Beijing), Ltd.. 1 FDA inspection on record, 1 Form 483, last inspected June 07, 2023.
Company Profile
This profile covers Evive Biopharmaceutical (Beijing), Ltd. based in United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 0
- Unclassified
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected June 7, 2023.
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| June 7, 2023 | Not classified | Human Drugs | 1209377 |
FDA documents
Form 483s (1)
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Catalent Pharma Solutions, LLC
FujiFilm Diosynth Biotechnologies U.S.A., Inc.
Patheon Biologics LLC
MacroGenics, Inc
Hangzhou Zhongmeihuadong Pharmaceutical Jiangdong Co., Ltd
Satya Deeptha Pharmaceuticals Limited
Binex Co., Ltd
Teva Biotech GmbH
Amoli Organics (A Division of Umedica Laboratories Pvt. Ltd.)
Ajinomoto Bio-Pharma Services India Private Limited
Company Information
Name
Evive Biopharmaceutical (Beijing), Ltd.
FEI Number
3013430082
Address
United States
Country
United States
ID: 34316aa6-0386-45be-883d-b7032a5cc0d0